AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 161 filers reported holding AGIOS PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 1.31 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,049 | -5.4% | 406 | +8.3% | 0.00% | – |
| Q2 2023 | $10,620 | +44.0% | 375 | +16.8% | 0.00% | – |
| Q1 2023 | $7,373 | -23.9% | 321 | -7.0% | 0.00% | – |
| Q4 2022 | $9,688 | +7.6% | 345 | +8.5% | 0.00% | – |
| Q3 2022 | $9,000 | +50.0% | 318 | +15.2% | 0.00% | – |
| Q2 2022 | $6,000 | +20.0% | 276 | +65.3% | 0.00% | – |
| Q1 2022 | $5,000 | +400.0% | 167 | +391.2% | 0.00% | – |
| Q4 2021 | $1,000 | – | 34 | +183.3% | 0.00% | – |
| Q3 2021 | $0 | -100.0% | 12 | -78.6% | 0.00% | – |
| Q4 2016 | $2,000 | 0.0% | 56 | 0.0% | 0.00% | – |
| Q3 2016 | $2,000 | 0.0% | 56 | -5.1% | 0.00% | – |
| Q2 2016 | $2,000 | 0.0% | 59 | 0.0% | 0.00% | – |
| Q1 2016 | $2,000 | -33.3% | 59 | 0.0% | 0.00% | -100.0% |
| Q4 2015 | $3,000 | -50.0% | 59 | -33.7% | 0.00% | 0.0% |
| Q3 2015 | $6,000 | -33.3% | 89 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $9,000 | +12.5% | 89 | +3.5% | 0.00% | 0.0% |
| Q1 2015 | $8,000 | – | 86 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 354,650 | $18,314,000 | 7.19% |
| Casdin Capital, LLC | 2,165,000 | $111,801,000 | 3.33% |
| Rock Springs Capital Management LP | 2,543,600 | $131,352,000 | 2.87% |
| HealthCor Management, L.P. | 1,532,960 | $79,162,000 | 2.80% |
| Bellevue Group AG | 4,537,092 | $234,295,000 | 2.48% |
| Woodline Partners LP | 824,097 | $42,556,000 | 0.94% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,081,347 | $55,841,000 | 0.83% |
| Integral Health Asset Management, LLC | 43,000 | $2,221,000 | 0.64% |
| ArrowMark Colorado Holdings LLC | 1,119,566 | $57,814,000 | 0.43% |
| Virtus ETF Advisers LLC | 18,328 | $946,000 | 0.40% |